RxDoctor Payments Data

Julie Flanagan

Adult Health · Princeton, ILNPI 1700113958

Payments from drug & device makers

$826in general payments, 2019–2025

Across 92 payments — averaging $8.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$568
  • AbbVie$140
  • Aimmune Therapeutics, Inc.$60
  • Astellas Pharma US Inc$25
  • Nestle Healthcare Nutrition Inc.$18
  • Ferring Pharmaceuticals Inc.$14

What the payments were for

  • Food & beverage$79196%
  • Education$354%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$826 in reported general payments places this provider in the 70th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois

Medicare billing

Part B allowed, 2024
$60,971
Medicare patients
574
Services billed
634

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide63$41,273
ZenpepLipase/Protease/Amylase23$34,512
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates286$18,916
CreonLipase/Protease/Amylase15$16,568
Mesalamine34$11,586
Mesalamine ErMesalamine32$9,281
Dexlansoprazole DrDexlansoprazole17$9,196
Esomeprazole Magnesium108$9,162
Famotidine804$7,096
Pantoprazole Sodium489$5,302
Budesonide DrBudesonide12$3,528
Omeprazole346$3,218
Lubiprostone12$2,444
Balsalazide Disodium16$1,935
Dicyclomine Hcl68$1,312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$140$57,84278 claims
Aimmune Therapeutics, Inc.Zenpep$60$34,51223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 553 adult health providers in Illinois.

Other adult health in Princeton

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →